Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

French maritime pine bark extract (Pycnogenol)

French Maritime Pine Bark Extract (Pycnogenol) · also known as Pycnogenol, Pycnogenol, French pine bark extract, High-purity oligomeric proanthocyanidin complex

A French maritime pine bark extract containing proanthocyanidins and phenolic acids. In small human trials it can enhance nitric oxide-dependent vasodilation. Human data support an improvement in endothelial function, but human evidence on its specific targets and on any direct antioxidant effect is still inadequate.

Typical dose: Standardized Pycnogenol 50–200 mg/day, taken with meals
Absorption and forms: It is readily water-soluble, and small phenolic acids can reach the bloodstream within 30 minutes. Gut microbes break oligomeric proanthocyanidins down into metabolites (such as M4/M6), but there is not enough human pharmacokinetic or pharmacodynamic evidence to say whether these metabolites have a sustained clinical effect.

Clinical uses and human evidence

Varicose veins and leg swelling

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Arcangeli 2000 · Fitoterapia · RCT · n=40 — Pycnogenol in chronic venous insufficiency

Osteoarthritis pain

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Cisár 2008 · Phytother Res · RCT · n=100 — Effect of pine bark extract (Pycnogenol) on symptoms of knee osteoarthritis
  2. Belcaro 2008 · Phytother Res · RCT · n=156 — Treatment of osteoarthritis with Pycnogenol. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of signs, symptoms, physical performance and vascular aspects

Menopause symptoms

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Kohama 2013 · J Reprod Med · RCT · n=170 — Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial

PMS and menstrual pain

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Suzuki 2008 · J Reprod Med · RCT · n=116 — French maritime pine bark extract significantly lowers the requirement for analgesic medication in dysmenorrhea: a multicenter, randomized, double-blind, placebo-controlled study

Blood sugar and insulin resistance

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Malekahmadi 2019 · Pharmacol Res · Meta-analysis · n=1594 — Effects of pycnogenol on cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials

Macular and vision protection

BeneficialGrade C · Preliminary evidence
Studies (1)
  1. Steigerwalt 2009 · J Ocul Pharmacol Ther · RCT · n=46 — Pycnogenol improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy

High blood pressure

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Malekahmadi 2019 · Pharmacol Res · Meta-analysis · n=1594 — Effects of pycnogenol on cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials

High LDL cholesterol

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Malekahmadi 2019 · Pharmacol Res · Meta-analysis · n=1594 — Effects of pycnogenol on cardiometabolic health: A systematic review and meta-analysis of randomized controlled trials

Heart attack, stroke and other cardiovascular events

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Belcaro 2017 · Minerva Cardioangiol · Cohort study · n=413 — Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events
  2. Belcaro 2020 · Minerva Cardioangiol · Cohort study — Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®

Mechanisms of action

Endothelial nitric oxide synthase (eNOS) coupling and NO vasodilation

★★★☆☆Mechanism evidence: grade BPrimary target

Small human trials showed that 180–200 mg/day can enhance nitric oxide-dependent vasodilation, and an NOS inhibitor abolished this enhancement. Upregulation of eNOS transcription and NO production itself were not measured directly. Evidence on the size of the improvement and on which populations benefit is still limited.

References (2)
  1. Nishioka 2007 · Small human randomized trial: 180 mg/day enhanced the acetylcholine-induced forearm blood flow response, and an NOS inhibitor abolished this enhancement.
  2. Enseleit 2012 · Human crossover RCT: 200 mg/day improved endothelium-dependent vasodilation (FMD) in patients with coronary artery disease.

Collagen triple-helix cross-linking and fibril synthesis

★★☆☆☆Mechanism evidence: grade BSecondary target

An uncontrolled study of 20 people found increased HAS-1 expression in skin biopsies, and genes related to collagen synthesis also trended upward. This is a small-sample mechanistic signal with no control group, and it does not demonstrate any direct effect on collagen formation, cross-linking or blood vessel wall repair.

References (1)
  1. Marini 2012 · 20-person uncontrolled study: HAS-1 expression in skin increased, and collagen synthesis-related gene expression showed signs of an increase.

Direct free radical trapping and chemical quenching

★☆☆☆☆Mechanism evidence: grade DSecondary target

In-vitro experiments showed that the extract can scavenge superoxide anion and peroxynitrite, but this cannot be directly extended to humans. After oral intake, the concentration and metabolism of the parent polyphenols limit any direct scavenging effect throughout the body, and whether it directly protects NO inside blood vessels has not been confirmed. A fall in human oxidative stress markers also cannot distinguish direct scavenging from indirect antioxidant effects.

References (2)
  1. Kim 2008 · In-vitro study: the extract scavenged several free radicals and peroxynitrite.
  2. Enseleit 2012 · Human RCT: lipid peroxidation markers fell, but the study did not separate direct scavenging from indirect antioxidant effects.

Safety and drug interactions

Generally well tolerated. A few people may get mild stomach discomfort when taking it on an empty stomach, so taking it with a meal is advised. It may have additive effects with antihypertensive, anticoagulant or antiplatelet drugs. Evidence on clinical interactions is limited, so anyone taking these drugs should use it under a doctor’s guidance.

Additive bleeding risk

Mildly inhibits platelet aggregation. Each of these has a mild antiplatelet or fibrinolytic effect. Alone, the effect is usually small, but when several are combined, the tendency to bleed becomes more noticeable. Stop them 1–2 weeks before surgery or a tooth extraction, and watch for gum bleeding or more bruising.

Open in the interactive app ›